Hong Kong is poised to grant its first stablecoin issuer licenses as early as March, marking a critical milestone in its bid to become a regulated digital asset hub. The HKMA's rigorous vetting process will initially see only a handful of firms approved from dozens of applicants.
With Warren Buffett's retirement, Berkshire Hathaway faces its most significant leadership transition. Yet, under new CEO Greg Abel, strategic portfolio shifts and a colossal war chest are fueling analyst optimism for the conglomerate's next chapter.
Nomura Holdings is implementing stricter risk controls at its digital asset subsidiary, Laser Digital, following significant crypto-related losses that contributed to a nearly 10% drop in its fiscal third-quarter profit, the firm's CEO confirmed.
Hong Kong's monetary authority will grant its first batch of stablecoin issuer licenses next month, with initial approvals limited to a select few firms as the city positions itself as a regulated hub for digital assets.
U.S. stock futures pointed to a lower open Monday, pressured by a sharp selloff in precious metals and renewed investor caution around AI sector valuations. All eyes turn to a packed week of corporate earnings and key labor market data for clues on the economy's trajectory.
With shares up over 100% in a year, investors are weighing whether to buy AMD stock before its February 3rd earnings report, as the chipmaker capitalizes on the AI boom.
Amid rising electricity prices and shifting federal incentives, solar platform GigaWatt is turning to crowd-investing to accelerate its push into integrated, user-friendly DIY solar kits, betting on AI and streamlined hardware to capture a growing market.
Fidelity Investments and Broadcom have settled a legal dispute that threatened Fidelity's access to business-critical software, averting a potential operational crisis. The agreement, reached just before a key court hearing, ensures continued service for a Fidelity subsidiary.
Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.
Zions Bancorporation has authorized a new $75 million stock repurchase program, a move analysts see as a bet on its undervalued shares and a commitment to shareholder returns as regional banks navigate a cautious regulatory environment.
IBM intensifies its focus on the enterprise AI market with the launch of its governed deployment platform, a strategic collaboration with e& for regulated sectors, and the appointment of PepsiCo's Ramon Laguarta to its board of directors.
Edwards Lifesciences (NYSE: EW) has terminated its planned takeover of JenaValve, opting instead to reinvest capital into its internal transcatheter aortic (TAVR) and mitral valve development programs. The strategic pivot underscores a renewed focus on organic growth in its core structural heart business.
Publicly-listed digital asset firm BitMine Immersion Technologies now holds over $10.7 billion in assets, with its massive Ethereum treasury positioning it to capture an estimated $374 million in annual staking rewards as it marches toward a controversial 5% supply goal.
Oracle plans a massive $45-50 billion capital raise to expand its cloud infrastructure for AI, backed by a record $523 billion order backlog. While securing its future in the AI race, the aggressive move exposes the tech giant to significant execution and financial risks as cash flow turns negative.
Israeli police have detained municipal officials and business figures suspected of embezzling millions in international donations intended for communities devastated by the October 7 Hamas attacks, launching a major fraud investigation.
Despite a recent 4.7% stock decline, Edwards Lifesciences (NYSE: EW) boasts a robust 13% Return on Equity, outperforming its industry. Yet, its modest 4.6% five-year growth rate raises questions about future potential and market valuation.
Investment firm Curreen Capital posted strong 2025 results, crediting its focus on undervalued 'ugly duckling' stocks. The fund's latest letter spotlights VF Corporation (VFC), the embattled owner of Vans and The North Face, as a potential turnaround play despite its shares falling over 20% in the past year.
The Walt Disney Company surpassed Wall Street's revenue and earnings expectations for its fiscal first quarter, powered by strength in its streaming services and theme parks. The media giant reaffirmed its full-year forecast for double-digit profit growth, signaling confidence in its ongoing strategic transformation.
Goldman Sachs CEO David Solomon, while optimistic on global markets, forecasts a deliberate deceleration in talent acquisition for 2026 as the bank sharpens its focus on operational efficiency and strategic resource allocation.
Amazon is negotiating a landmark investment of up to $50 billion in OpenAI, according to sources familiar with the matter. The move could position the tech giant as the lead investor in a funding round aiming to raise up to $100 billion ahead of a potential trillion-dollar IPO.
